Aging on purpose. Strength, longevity & preventive health after 50. Down 170 lbs on TRT + GLP-1. I read the studies, track my labs and test this stuff on myself

Boston, MA
Joined September 2025
I’m Gunnar. I’m over 50, down roughly 170 lbs, lift regularly, and use TRT + a GLP-1 prescribed by my doctor. I became interested in something pretty simple: how do you get older without surrendering muscle, cardiovascular health or independence — and how much of the longevity industry is actually supported by evidence? So I read the studies, track my own labs and write about what I find. Strength training. Obesity medicine. TRT. Preventive health. Longevity. Occasionally calling bullshit. That’s DadStrengthDaily.
1
3
428
A federal judge today denied Novo's request to pull Lilly's Zepbound vs Wegovy and Mounjaro vs Ozempic ads. Novo argued the trials behind them skipped its newer, higher doses. The judge said Novo hadn't shown harm: its prescriptions held steady while the ads ran.
2
1
1
712
The judge also found Novo had run the same kind of ad: Ozempic-beats-Trulicity claims after Lilly's higher Trulicity doses were approved, with no disclaimer. Novo pulled them days before suing. The case continues. Opinion:
 storage.courtlistener.com/re…
3
1
2
656
This is wild. My Nest Protects all loudly announce *every* evening when I turn off the lights that they are going to expire in 3 months! Who thought that is a good idea?! FWIW, I already ordered replacements but still have to listen to this every night! Cc @googlenesthelp
1
1
457
I checked 93 stores that list "research use only" peptides like retatrutide and BPC-157. 23 openly publish mixing or dosing instructions, a dosing calculator, or health claims. Another 24 list bacteriostatic water. 19 of the 93 already have an FDA warning letter.
6
3
272
The label has not held up in court. Paradigm Peptides told the FDA in 2022 its products were "for research only" and sold until 2024. Its owner got 70 months in July: unapproved drugs sold with intent to defraud, plus illegal imports. Part 1 of 3: dadstrengthdaily.com/researc…
47
New hematology guideline: call iron deficiency at a ferritin of 30 or lower, not 15. In the pooled studies, 15 caught 41% of iron-deficient people and 30 caught 67%. Mine was 14, 22 and 24. In a man, that needs an explanation. dadstrengthdaily.com/low-fer…
1
62
TRIUMPH-1's NEJM appendix: 22.5% on retatrutide 12 mg had the dose permanently cut. Top reason: "perceived excessive weight loss" (9.8%), ahead of GI side effects (6.2%). They still count in the 28.3% headline. On 4 mg, 3 in 4 stayed on it. dadstrengthdaily.com/retatru…
3
3
13
906
Is Scientific American really adopting the illegal peptide grey market “GLP-3” terminology? Why?
2
4
246
The peptide brand Sam Sulek says he co-owns sold a $285 retatrutide pen. Its own label says putting it into a human is "strictly prohibited by law." A site with the same logo showed you how to give yourself a shot. Retatrutide isn't approved anywhere.
1
2
340
New JAMA IM study, 101,148 patients: eating within 8h of a blood draw raised glucose 11% and triglycerides 20%. Cholesterol, LDL, HDL, blood count, kidney tests held steady. Fasting past 12h made no meaningful difference vs 8 to 12h. dadstrengthdaily.com/how-lon…
21
Gunnar · DadStrengthDaily retweeted
Follow the link below to claim the credit or run /claim-credit in the CLI. You’ll need GitHub connected to start a session. Claim by Oct 7. Terms apply. claude.ai/code/claim-credit/…
158
559
265
6,936
5,869,088
Town hacked, Google inadvertently promoting a Chinese peptide seller on WhatsApp. Two weeks and running. The Town of Stoneville, NC's real government website was compromised. Google's crawler gets a normal-looking article; everyone else gets redirected into a WhatsApp group selling grey-market peptides, "30% off first order." Reported to the town, MS-ISAC, the host, and Google on day one — the site looked cleaned up for 5 days, then the redirect came right back. dadstrengthdaily.com/nc-town…
61
Brenipatide. It's a Lilly GLP-1, and it has nothing to do with weight loss. Four Phase 3 trials in alcohol use disorder and major depression, about 4,200 people. Not Zepbound, not Mounjaro — a different molecule entirely. It's the only drug in this class with a company chasing those two approvals.
49
Novo ran CagriSema at two doses in REDEFINE 9. The lower 1.0/1.0 mg gave 20.95% weight loss at 68 weeks. The higher 1.7/1.7 mg gave 20.75%, slightly worse. That second number is in a footnote of today's investor slides. GLP-1 tracker updated dadstrengthdaily.com/glp1-pi…
1
50